"Moderna sharpens focus on $1.5bn cost cutting plan after 41% revenue slump" was originally created and published by ...

The biotech company reported second-quarter financial results on Friday ahead of market open, a day after announcing plans to ...

The Moderna layoffs are aimed at cutting costs amid declining vaccine sales and a shifting regulatory landscape.

The FDA greenlit multiple new drugs this month and issued some notable label expansions, including for Eli Lilly’s Kisunla.

The layoffs come as Moderna’s cash position has raised worries on Wall Street that the company may need to raise new capital.

Moderna is downsizing its workforce by 10% globally to bring headcount to under 5,000 in “a difficult moment for the company, ...

The layoffs make up about 10% of Moderna's global workforce, CEO Stéphane Bancel said in a staff memo on Thursday, July 31. The Cambridge, Massachusetts, biotech firm is trying to cut $1.5 billion in ...

Moderna (MRNA) stock in focus as the company plans to cut 10% of its workforce by 2025 amid cost-saving efforts. Read more ...

Moderna Inc. (NASDAQ: MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year ...

The scale of the Merck layoffs has not been revealed, but the company indicated that it would target roles in the ...

BioMarin Pharmaceuticals is one of many biotech companies that’s laid off workers over the past two years. Its office in ...

Fortune Cuts 10% of Staff, Becomes Latest Media Company Hit With AI-Driven Layoffs CEO Anastasia Nyrkovskaya says the cuts are due to a decline in web traffic and the “onset of AI” ...